BridgeBio Oncology Therapeutics, Inc. (BBOT)

BBOT Statistics

Total Valuation

BBOT has a market cap or net worth of $681.08 million. The enterprise value is $431.45 million.

Market Cap	681.08M
Enterprise Value	431.45M

Important Dates

The last earnings date was Tuesday, May 12, 2026, after market close.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

BBOT has 80.03 million shares outstanding. The number of shares has increased by 37,145.03% in one year.

Current Share Class	80.03M
Shares Outstanding	80.03M
Shares Change (YoY)	+37,145.03%
Shares Change (QoQ)	-99.90%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	42.75%
Float	35.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.83
P/TBV Ratio	1.83
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.16, with a Debt / Equity ratio of 0.01.

Current Ratio	6.16
Quick Ratio	5.83
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -62.21% and return on invested capital (ROIC) is -42.16%.

Return on Equity (ROE)	-62.21%
Return on Assets (ROA)	-37.20%
Return on Invested Capital (ROIC)	-42.16%
Return on Capital Employed (ROCE)	-45.10%
Weighted Average Cost of Capital (WACC)	5.44%
Revenue Per Employee	n/a
Profits Per Employee	-$1.67M
Employee Count	92
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.22
52-Week Price Change	n/a
50-Day Moving Average	8.87
200-Day Moving Average	n/a
Relative Strength Index (RSI)	49.34
Average Volume (20 Days)	443,785

Short Selling Information

The latest short interest is 3.32 million, so 4.15% of the outstanding shares have been sold short.

Short Interest	3.32M
Short Previous Month	3.24M
Short % of Shares Out	4.15%
Short % of Float	9.31%
Short Ratio (days to cover)	6.99

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-168.86M
Pretax Income	-154.10M
Net Income	-154.10M
EBITDA	-168.56M
EBIT	-168.86M
Earnings Per Share (EPS)	-$4.96

Balance Sheet

The company has $252.28 million in cash and $2.64 million in debt, with a net cash position of $249.63 million or $3.12 per share.

Cash & Cash Equivalents	252.28M
Total Debt	2.64M
Net Cash	249.63M
Net Cash Per Share	$3.12
Equity (Book Value)	372.28M
Book Value Per Share	4.65
Working Capital	223.24M

Cash Flow

In the last 12 months, operating cash flow was -$130.21 million and capital expenditures -$468,000, giving a free cash flow of -$130.68 million.

Operating Cash Flow	-130.21M
Capital Expenditures	-468,000
Depreciation & Amortization	300,000
Net Borrowing	n/a
Free Cash Flow	-130.68M
FCF Per Share	-$1.63

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BBOT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37,145.03%
Shareholder Yield	-37,145.03%
Earnings Yield	-22.63%
FCF Yield	-19.19%

Analyst Forecast

The average price target for BBOT is $23.88, which is 180.61% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$23.88
Price Target Difference	180.61%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2